✦ LIBER ✦

High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results

✍ Scribed by Bertucci, F; Viens, P; Delpero, J R; Bardou, V J; Faucher, C; Houvenaeghel, G; Maraninchi, D

Book ID: 110012641
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 75 KB
Volume: 26
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702468

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma : Long term results for 105 patients

✍ Takao Shinozuka; Tsuyoshi Miyamoto; Toshinari Muramatsu; Takeshi Hirasawa; Masar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## BACKGROUND. In this study, the authors reviewed long term results and prognostic factors of high dose chemotherapy (HDC) with autologous stem cell support administered to 105 patients with epithelial ovarian carcinoma. ## METHODS. Prior to HDC, platinum-based chemotherapy was given to optimi

High-dose melphalan and autologous stem

High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial

✍ Papadimitriou, C; Dafni, U; Anagnostopoulos, A; Vlachos, G; Voulgaris, Z; Rodola 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 204 KB

Long-term followup of health status in p

Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation

✍ Y. K. O. Teng; R. J. Verburg; J. K. Sont; W. B. Van Den Hout; F. C. Breedveld; J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

High-dose therapy and autologous stem ce

High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell lymphoma

✍ Zamkoff, K W; Matulis, M D; Mehta, A C; Beaty, M W; Hutchison, R E; Gentile, T C 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB